TDP-43 based biomarker development in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis is a devastating neurodegenerative disease which is clinically and aetiologically heterogenous. However, TDP-43 neuropathology is a unifying hallmark found in 97% of ALS cases. Understanding the common pathological pathways downstream of TDP-43 dysregulation is essentia...
المؤلف الرئيسي: | Feneberg, E |
---|---|
مؤلفون آخرون: | Turner, M |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
2019
|
الموضوعات: |
مواد مشابهة
-
Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
حسب: Rachel H. Tan, وآخرون
منشور في: (2023-11-01) -
Advancements in TDP-43 research: Towards biomarkers and therapeutic targets for amyotrophic lateral sclerosis
حسب: Yuhan Wu, وآخرون
منشور في: (2025-03-01) -
The role of TDP-43 protein in amyotrophic lateral sclerosis
حسب: Piotr Włodarczyk, وآخرون
منشور في: (2022-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
حسب: Joanna Iłżecka
منشور في: (2017-12-01) -
Kinesitherapy in amyotrophic lateral sclerosis
حسب: Joanna Iłżecka
منشور في: (2017-12-01)